Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

485
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
485
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

81
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
81
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

1.6K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.6K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

396
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
396
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

71
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
71
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

73
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
73

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Amphipathic KALA fusogenic peptide enhances absorption of insulin and calcitonin by pulmonary membranes of rats.

European review for medical and pharmacological sciences·2024
Same author

Functional role of NKX2-5 and Smad6 expression in developing rheumatic heart disease.

European review for medical and pharmacological sciences·2016
Same author

The ribosomal DNA loci in Plasmodium falciparum accumulate mutations independently.

Journal of molecular biology·1995
Same author

Binding of phenylarsenoxide to Arg-tRNA protein transferase is independent of vicinal thiols.

Biochemistry·1995
Same author

The oncogene qin codes for a transcriptional repressor.

Cancer research·1995
Same author

Non-receptor cytosolic protein tyrosine kinases from various rat tissues.

Biochimica et biophysica acta·1995

Related Experiment Video

Updated: Oct 16, 2025

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart
08:22

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart

Published on: April 15, 2020

18.7K

The decrease of endothelial progenitor cells caused by high altitude may lead to coronary heart disease.

X-Q Ha1, J Li, C-P Mai

  • 1The 940th Hospital of Joint Logistics Support Force of PLA, Lanzhou, Gansu, China. haxiaoqin20@21cn.com.

European Review for Medical and Pharmacological Sciences
|October 18, 2021
PubMed
Summary

Endothelial progenitor cells (EPCs) are reduced in patients with coronary heart disease (CHD). This decrease, potentially linked to high altitude, may elevate inflammatory cytokines, contributing to CHD development.

More Related Videos

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.5K
Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery
08:43

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery

Published on: February 14, 2017

11.1K

Related Experiment Videos

Last Updated: Oct 16, 2025

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart
08:22

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart

Published on: April 15, 2020

18.7K
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.5K
Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery
08:43

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery

Published on: February 14, 2017

11.1K

Area of Science:

  • Cardiovascular Research
  • Cell Biology
  • Environmental Health

Background:

  • Coronary heart disease (CHD) is a significant global health concern.
  • Endothelial progenitor cells (EPCs) play a crucial role in vascular repair and endothelial function.
  • Factors influencing EPC levels and their association with CHD require further investigation.

Purpose of the Study:

  • To investigate the relationship between the number of EPCs and the presence of CHD.
  • To explore potential environmental influences, such as high altitude, on EPC levels and CHD risk.

Main Methods:

  • A case-control study involving 24 CHD patients and 24 matched healthy controls from Lanzhou and Xianyang cities.
  • Measurement of EPC counts.
  • Assay of serum biomarkers including C-reactive protein (CRP), high-sensitivity CRP (hs-CRP), interleukin-8 (IL-8), vascular endothelial growth factor (VEGF), homocysteine (Hcy), hypoxia-inducible factor-1α (HIF-1α), and stromal cell-derived factor 1 (SDF-1α).

Main Results:

  • EPC numbers were significantly lower in CHD patients compared to controls.
  • Higher levels of total cholesterol (TC), LDL, and CRP were observed in the CHD group.
  • Specific biomarker profiles differed between the two cities, with variations in IL-8, VEGF, HIF-1α, and Hcy levels.
  • A negative correlation was found between EPC count and hs-CRP in the Lanzhou CHD group.

Conclusions:

  • Reduced EPC levels may be associated with an increased risk of developing CHD.
  • Environmental factors, potentially high altitude, might contribute to EPC reduction and subsequent cytokine dysregulation, promoting CHD.
  • Further research is warranted to elucidate the precise mechanisms linking EPCs, environmental factors, and CHD pathogenesis.